[Stages of the development of new biologically active suture materials and using them in the emergency abdominal surgery] [0.03%]
新型生物活性缝合材料的研发过程及其在战伤腹部外科手术中应用展望
E M Mokhov,A N Sergeev,R Iu Chumakov et al.
E M Mokhov et al.
After experimental investigations the antimicrobial suture materials Nikant and Nikant P were used in clinical practice (in operations on 985 patients). It was shown that the frequency of local complications after surgery using the antimicr...
Comparative Study
Vestnik khirurgii imeni I. I. Grekova. 2009;168(6):25-8. DOI: 2009
[Substantiation of clinical application for hernioplasty of reticulate prosthesis with antimicrobial properties] [0.03%]
具有抗菌性能的网片材料疝修补术临床应用依据
N A Postrelov,G E Afinogenov,B Ia Basin et al.
N A Postrelov et al.
A new reticulate hernioprosthesis has been developed and proposed for clinical use. The adhesive high molecular polymer coating containing silver nanoclusters was applied on the lavsan network. After implantation the polymer was dissolved i...
Comparative Study
Vestnik khirurgii imeni I. I. Grekova. 2009;168(6):21-4. DOI: 2009
[Improvement of differential diagnostics and prognostication of the course of destructive forms of acute pancreatitis] [0.03%]
急性胰腺炎坏死性病变的诊断及病程判断的新方法
Iu S Vinnik,S V Miller,O V Tepliakova
Iu S Vinnik
A complex dynamic investigation of the state of oxidative homeostasis in patients with different forms of acute pancreatitis has shown that a reliable reduction of the indices of maximal intensity of chemiluminescence and the coefficient of...
Comparative Study
Vestnik khirurgii imeni I. I. Grekova. 2009;168(6):16-20. DOI: 2009
S F Bagnenko,A A Kurygin,G I Sinenchenko et al.
S F Bagnenko et al.
Based on an experience with treatment of 269 patients with complicated peptic ulcer the authors came to a conclusion that the most sparing and radical operation was subdiaphragmatic truncal vagotomy with Finney pyloroplasty with lethality o...
Comparative Study
Vestnik khirurgii imeni I. I. Grekova. 2009;168(6):12-5. DOI: 2009
D Iu Boiarinov,I V Timergalin
D Iu Boiarinov
[Certain possible complications and side effects after the introduction of interleukin-2 in the scheme of treatment of surgical patients] [0.03%]
[关于在手术治疗方案中使用干扰素-2后可能出现的若干并发症和副作用]
I V Maĭborodin,A I Shevela,D V Egorov et al.
I V Maĭborodin et al.
S P Gliantsev,A V Andreeva,E A Shkuratova
S P Gliantsev
Iu L Shevchenko,M N Kozovenko
Iu L Shevchenko
I N Zubarovskiĭ,K A Plutakhin
I N Zubarovskiĭ
Case Reports
Vestnik khirurgii imeni I. I. Grekova. 2009;168(5):71-2. DOI: 2009